Showing results (391-400 of 532) with videos related to

Sort By:
Pageof 54
Clinical Pharmacology and Therapeutics|February 13, 2022
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal SymptomsRhonda M Cooper-DeHoff, Mikko Niemi, Laura B Ramsey, et al.
Assay and Drug Development Technologies|April 6, 2017
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human GeneticsJill M Pulley, Jana K Shirey-Rice, Robert R Lavieri, et al.
Science (New York, N.Y.)|February 26, 2016
The phenotypic legacy of admixture between modern humans and NeandertalsCorinne N Simonti, Benjamin Vernot, Lisa Bastarache, et al.
JACC. Clinical Electrophysiology|July 26, 2023
Pulmonary Vein Myocardial Sleeve Length and its Association With Sex and 4q25/PITX2 GenotypeMajd A El-Harasis, Zachary T Yoneda, Giovanni E Davogustto, et al.
Bioinformatics (Oxford, England)|December 6, 2022
Interactive network-based clustering and investigation of multimorbidity association matrices with associationSubgraphsNick Strayer, Siwei Zhang, Lydia Yao, et al.
Communications Medicine|May 5, 2026
Multi-scale data improves performance of machine learning model for long COVID identificationChristopher Guardo, Zhang Xinmeng, Srushti Gangireddy, et al.
Circulation. Cardiovascular Genetics|October 27, 2016
Defining a Contemporary Ischemic Heart Disease Genetic Risk Profile Using Historical DataJonathan D Mosley, Sara L van Driest, Quinn S Wells, et al.
Evolutionary Computation, Machine Learning and Data Mining in Bioinformatics. Evobio (Conference)|January 16, 2015
Replication of SCN5A Associations with Electrocardio-graphic Traits in African Americans from Clinical and Epidemiologic StudiesJanina M Jeff, Kristin Brown-Gentry, Robert Goodloe, et al.
Blood|April 4, 2022
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopeniaJason H Karnes, Jerome Rollin, Jason B Giles, et al.
Circulation. Arrhythmia and Electrophysiology|July 25, 2025
2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot TrialZachary T Yoneda, Matthew O'Neill, Diane M Crawford, et al.
Pageof 54